Abstract

The phenomenon that adverse environmental exposures in early life are associated with increased susceptibilities for many adult, particularly metabolic diseases, is now referred to as ‘developmental origins of health and disease (DOHAD)’ or ‘Barker’ hypothesis. Fetal overnutrition and undernutrition have similar long-lasting effects on the setting of the neuroendocrine control systems, energy homeostasis, and metabolism, leading to life-long increased morbidity. There are sensitive time windows during early development, where environmental cues can program persistent epigenetic modifications which are generally assumed to mediate these gene–environment interactions. Most of our current knowledge on fetal programing comes from animal models and epidemiological studies in humans, in particular the Dutch famine birth cohort. In industrialized countries, there is more concern about adverse long-term consequences of fetal overnutrition, i.e. by exposure to gestational diabetes mellitus and/or maternal obesity which affect 10–20% of pregnancies. Epigenetic changes due to maternal diabetes/obesity may predispose the offspring to develop metabolic disease later in life and, thus, transmit the adverse environmental exposure to the next generation. This vicious cycle could contribute significantly to the worldwide metabolic disease epidemics. In this review article, we focus on the epigenetics of an adverse intrauterine environment, in particular gestational diabetes, and its implications for the prevention of complex disease.

Highlights

  • As early as 1880, puerperal diabetes has been associated with severe fetal and neonatal complications (Duncan 1882)

  • In the 1950s, the term ‘gestational diabetes mellitus (GDM)’ was coined for a carbohydrate intolerance that develops during pregnancy and usually resolves after birth (Carrington et al 1957)

  • When the maternal b-cells cannot adapt to the increased food supply to the fetus and increased insulin demands during late pregnancy, the blood glucose levels will rise, stimulating insulin production of the fetal pancreas (Perkins et al 2007)

Read more

Summary

Introduction

As early as 1880, puerperal diabetes has been associated with severe fetal and neonatal complications (Duncan 1882). In a streptozotocin-induced GDM mouse model, intrauterine hyperglycemia was associated with impaired glucose tolerance and abnormal insulin levels in the F1 and F2 offspring, which may be related with abnormal methylation and expression of the IGF2-H19 locus in pancreatic islets and impaired islet structure and function (Ding et al 2012).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call